Skip to main content

RootPath Announces Presentation and Fireside Chat at Built With Biology 2022

RootPath, a synthetic biology company that elevates the throughput of gene function interrogation by orders of magnitude, today announced that CEO and Co-Founder, Xi Chen, will present an overview of RootPath’s gene synthesis platform PathFinder DNA Assembly™ and Nano Toothpick™ at the Built With Biology Conference on April 13, 2022 at 12:30 pm PDT in Oakland, California.

Susana Donkor, a research associate at RootPath, will participate in a fireside chat at the Built With Biology Conference on April 12, 2022 at 5:25 PM PDT.

About RootPath

RootPath is a synthetic biology company that elevates the throughput of gene function interrogation by orders of magnitude. Our Molecular Programming-based DNA fragment assembly technology gives researchers and drug developers unprecedented, equitable access to long synthetic genes and their functional readouts. By applying our technology to mine a patient’s immunome, we create truly personalized T cell therapies for solid tumors. Together, with leading partners, we are exploring new applications across multiple industries. We enable biology at scale.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  210.11
+5.25 (2.56%)
AAPL  264.58
+4.00 (1.54%)
AMD  200.15
-3.22 (-1.58%)
BAC  53.06
+0.29 (0.55%)
GOOG  314.90
+11.34 (3.74%)
META  655.66
+10.88 (1.69%)
MSFT  397.23
-1.23 (-0.31%)
NVDA  189.82
+1.92 (1.02%)
ORCL  148.08
-8.46 (-5.40%)
TSLA  411.82
+0.11 (0.03%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.